A Lateral Flow Test for Staphylococcus aureus in Nasal Mucus Using a New DNAzyme as the Recognition Element

Angew Chem Int Ed Engl. 2022 Jan 17;61(3):e202112346. doi: 10.1002/anie.202112346. Epub 2021 Dec 2.

Abstract

Detection of pathogenic bacteria in complex biological matrices remains a major challenge. Herein, we report the selection and optimization of a new DNAzyme for Staphylococcus aureus (SA) and the use of the DNAzyme to develop a simple lateral flow device (LFD) for detection of SA in nasal mucus. The DNAzyme was generated by in vitro selection using a crude extra/intracellular mixture derived from SA, which could be used directly for simple solution or paper-based fluorescence assays for SA. The DNAzyme was further modified to produce a DNA cleavage fragment that acted as a bridging element to bind DNA-modified gold nanoparticles to the test line of a LFD, producing a simple colorimetric dipstick test. The LFD was evaluated with nasal mucus samples spiked with SA, and demonstrated that SA detection was possible in minutes with minimal sample processing.

Keywords: Biosensor; DNAzyme; Lateral flow device; SELEX; Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biosensing Techniques*
  • DNA, Catalytic / metabolism*
  • Humans
  • Mucus / microbiology*
  • Nasal Cavity / microbiology*
  • Staphylococcus aureus / isolation & purification*
  • Staphylococcus aureus / metabolism

Substances

  • DNA, Catalytic